Literature DB >> 14618267

Urochordates carry multiple genes for goose-type lysozyme and no genes for chicken- or invertebrate-type lysozymes.

I W Nilsen1, B Myrnes, R B Edvardsen, D Chourrout.   

Abstract

Genome clones and expressed sequence tags (ESTs) from the ascidian Ciona intestinalis and from the larvacean Oikopleura dioica were analysed for the presence of lysozyme-encoding genes. Two genes were found to potentially code for goose-type lysozymes in Oikopleura, while three or possibly more g-type proteins form the lysozyme complement of C. intestinalis, and at least one of these genes from each species is expressed based on EST data. No genes for chicken- or invertebrate-type lysozymes were found in either urochordate species. Consistent with this finding, extracts of Oikopleura animals possessed hydrolysing activity on bacterial cell walls, and this activity was not inhibited in the presence of a known inhibitor of chicken-type lysozyme. A wide range of isoelectric points for the predicted lysozymes from Ciona (pI 4.4, 6.4 and 9.9) and from Oikopleura (pI 5.0 and 8.0) suggests tissue-specific adaptations as well as specific functional roles of the lysozymes. Comparisons of gene structures, encoded sequences, cysteine residue content and their positions in the proteins indicate that the g-type lysozymes of Ciona intestinalis are more closely related to those of vertebrates than are the g-type lysozymes of Oikopleura. Multiple genes from each species may result from separate and lineage-specific duplications followed by functional specialisation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14618267     DOI: 10.1007/s00018-003-3252-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  37 in total

1.  Closure of large percutaneous access sites using the Prostar XL Percutaneous Vascular Surgery device.

Authors:  P C Haas; Z Krajcer; E B Diethrich
Journal:  J Endovasc Surg       Date:  1999-05

2.  Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.

Authors:  Alec Vahanian; Helmut Baumgartner; Jeroen Bax; Eric Butchart; Robert Dion; Gerasimos Filippatos; Frank Flachskampf; Roger Hall; Bernard Iung; Jaroslaw Kasprzak; Patrick Nataf; Pilar Tornos; Lucia Torracca; Arnold Wenink
Journal:  Eur Heart J       Date:  2007-01-26       Impact factor: 29.983

3.  Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system.

Authors:  Eberhard Grube; Lutz Buellesfeld; Ralf Mueller; Barthel Sauren; Bernfried Zickmann; Dinesh Nair; Harald Beucher; Thomas Felderhoff; Stein Iversen; Ulrich Gerckens
Journal:  Circ Cardiovasc Interv       Date:  2008-12       Impact factor: 6.546

4.  First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis.

Authors:  Eberhard Grube; Jean C Laborde; Bernfried Zickmann; Ulrich Gerckens; Thomas Felderhoff; Barthel Sauren; Andreas Bootsveld; Lutz Buellesfeld; Stein Iversen
Journal:  Catheter Cardiovasc Interv       Date:  2005-12       Impact factor: 2.692

5.  Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description.

Authors:  Alain Cribier; Helene Eltchaninoff; Assaf Bash; Nicolas Borenstein; Christophe Tron; Fabrice Bauer; Genevieve Derumeaux; Frederic Anselme; François Laborde; Martin B Leon
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

6.  Transapical transcatheter aortic valve implantation in humans: initial clinical experience.

Authors:  Samuel V Lichtenstein; Anson Cheung; Jian Ye; Christopher R Thompson; Ronald G Carere; Sanjeevan Pasupati; John G Webb
Journal:  Circulation       Date:  2006-07-31       Impact factor: 29.690

Review 7.  Aortic valve replacement in the elderly: frequently indicated yet frequently denied.

Authors:  Katrina A Bramstedt
Journal:  Gerontology       Date:  2003 Jan-Feb       Impact factor: 5.140

8.  Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience.

Authors:  Alain Cribier; Helene Eltchaninoff; Christophe Tron; Fabrice Bauer; Carla Agatiello; Deborah Nercolini; Sydney Tapiero; Pierre-Yves Litzler; Jean-Paul Bessou; Vasilis Babaliaros
Journal:  J Am Coll Cardiol       Date:  2006-02-09       Impact factor: 24.094

9.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

Authors:  M Lindroos; M Kupari; J Heikkilä; R Tilvis
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

10.  Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly.

Authors:  Fleur Descoutures; Dominique Himbert; Laurent Lepage; Bernard Iung; Delphine Détaint; Didier Tchetche; Eric Brochet; Yves Castier; Jean-Pol Depoix; Patrick Nataf; Alec Vahanian
Journal:  Eur Heart J       Date:  2008-03-06       Impact factor: 29.983

View more
  14 in total

1.  Identification of genes potentially related to biomineralization and immunity by transcriptome analysis of pearl sac in pearl oyster Pinctada martensii.

Authors:  Xiaoxia Zhao; Qingheng Wang; Yu Jiao; Ronglian Huang; Yuewen Deng; Huan Wang; Xiaodong Du
Journal:  Mar Biotechnol (NY)       Date:  2012-02-16       Impact factor: 3.619

Review 2.  Lysozymes in the animal kingdom.

Authors:  Lien Callewaert; Chris W Michiels
Journal:  J Biosci       Date:  2010-03       Impact factor: 1.826

3.  Structural evidence for lack of inhibition of fish goose-type lysozymes by a bacterial inhibitor of lysozyme.

Authors:  Peter Kyomuhendo; Inge W Nilsen; Bjørn Olav Brandsdal; Arne O Smalås
Journal:  J Mol Model       Date:  2008-05-20       Impact factor: 1.810

4.  Structural basis of bacterial defense against g-type lysozyme-based innate immunity.

Authors:  S Leysen; L Vanderkelen; S D Weeks; C W Michiels; S V Strelkov
Journal:  Cell Mol Life Sci       Date:  2012-10-21       Impact factor: 9.261

5.  Identification of a bacterial inhibitor against g-type lysozyme.

Authors:  L Vanderkelen; J M Van Herreweghe; K G A Vanoirbeek; G Baggerman; B Myrnes; P J Declerck; I W Nilsen; C W Michiels; L Callewaert
Journal:  Cell Mol Life Sci       Date:  2010-08-25       Impact factor: 9.261

6.  Molecular cloning, characterization, expression and antibacterial analysis of a lysozyme homologue from Fenneropenaeus merguiensis.

Authors:  Wei-jun Mai; Chao-qun Hu
Journal:  Mol Biol Rep       Date:  2008-09-17       Impact factor: 2.316

7.  Two goose-type lysozymes in Mytilus galloprovincialis: possible function diversification and adaptive evolution.

Authors:  Qing Wang; Linbao Zhang; Jianmin Zhao; Liping You; Huifeng Wu
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

8.  The genome- and transcriptome-wide analysis of innate immunity in the brown planthopper, Nilaparvata lugens.

Authors:  Yan-Yuan Bao; Lv-Yu Qu; Dong Zhao; Li-Bo Chen; Hong-Yuan Jin; Liang-Min Xu; Jia-An Cheng; Chuan-Xi Zhang
Journal:  BMC Genomics       Date:  2013-03-09       Impact factor: 3.969

9.  A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria.

Authors:  Lien Callewaert; Abram Aertsen; Daphne Deckers; Kristof G A Vanoirbeek; Lise Vanderkelen; Joris M Van Herreweghe; Barbara Masschalck; Dorothy Nakimbugwe; Johan Robben; Chris W Michiels
Journal:  PLoS Pathog       Date:  2008-03-07       Impact factor: 6.823

10.  Evolution of the vertebrate goose-type lysozyme gene family.

Authors:  David M Irwin
Journal:  BMC Evol Biol       Date:  2014-08-29       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.